ACER Acer Therapeutics Inc.

2.09
+0.14  (+7%)
Previous Close 1.95
Open 1.99
Price To Book 0.77
Market Cap 21,098,918
Shares 10,095,176
Volume 481,895
Short Ratio
Av. Daily Volume 397,204

NewsSee all news

  1. CLASS ACTION NOTICE: Brodsky & Smith, LLC Reminds Investors of Deadline Regarding Investigation of Securities Violations
  2. FDX, ACER & DBD Class Action - Bronstein, Gewirtz & Grossman, LLC
  3. Zhang Investor Law Reminds Investors of August 30 Deadline in Securities Class Action Lawsuit Against Acer Therapeutics Inc. – ACER
  4. FDX, ACER & DBD Class Action Update and Upcoming Deadline - Bronstein, Gewirtz & Grossman, LLC
  5. IMPORTANT AUGUST DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued June 25, 2019.
EDSIVO
Vascular Ehlers-Danlos Syndrome
Phase 2b trial did not meet primary endpoint - October 28, 2016.
Tovaxin (Tcelna)
Secondary Progressive MS (SPMS)
Pivotal bridging trial to be initiated 4Q 2019 with NDA filing mid-2020.
ACER-001
Urea cycle disorder (UCD)
Phase 1/2 trial to be initiated mid-2020.
Osanetant
induced Vasomotor Symptoms (iVMS)

Latest News

  1. CLASS ACTION NOTICE: Brodsky & Smith, LLC Reminds Investors of Deadline Regarding Investigation of Securities Violations
  2. FDX, ACER & DBD Class Action - Bronstein, Gewirtz & Grossman, LLC
  3. Zhang Investor Law Reminds Investors of August 30 Deadline in Securities Class Action Lawsuit Against Acer Therapeutics Inc. – ACER
  4. FDX, ACER & DBD Class Action Update and Upcoming Deadline - Bronstein, Gewirtz & Grossman, LLC
  5. IMPORTANT AUGUST DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  6. Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Sunlands, Fred’s, and Acer Therapeutics and Encourages Investors to Contact the Firm
  7. SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACER
  8. FDX, ACER & DBD Class Action Reminder and Upcoming Deadline - Bronstein, Gewirtz & Grossman, LLC
  9. SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces Investigation of Securities Violations
  10. Acer Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
  11. DEADLINE APPROACHING: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Acer Therapeutics, Inc.
  12. FDX, ACER & DBD Class Action and Upcoming Deadline - Bronstein, Gewirtz & Grossman, LLC
  13. UPCOMING DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  14. Factors Setting the Tone for Deere (DE) in Q3 Earnings
  15. CLASS ACTION DEADLINE: Brodsky & Smith, LLC Reminds Investors of Deadlines Regarding Investigation of Securities Violations
  16. Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eros International, Sunlands Technology, Fred’s, and Acer Therapeutics and Encourages Investors to Contact the Firm